Comparative effects of 1,25(OH)2D3 and EB1089 on cell cycle kinetics and apoptosis in MCF-7 breast cancer cells

Breast Cancer Research and Treatment

Volumn 42, Issue 1, 1997, Pages 31-41

  Simboli Campbell, Maura ^a   Narvaez, Carmen J ^b   VanWeelden, Kathryn ^b   Tenniswood, Martin ^b   Welsh, JoEllen ^b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b Adirondack Biomedical Research Institute Inc   (United States)

Author keywords

Apoptosis; Breast cancer; Cell cycle; MCF 7 cells; Vitamin D analogs

Indexed keywords

CALCITRIOL; DNA FRAGMENT; SEOCALCITOL;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CANCER INHIBITION; CELL COUNT; CELL GROWTH; CHROMATIN CONDENSATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BREAST NEOPLASMS; CALCITRIOL; CELL CYCLE; CELL SURVIVAL; DNA FRAGMENTATION; DOWN-REGULATION; HUMANS; NEOPLASM PROTEINS; PHOSPHORYLATION; RECEPTORS, ESTROGEN; RETINOBLASTOMA PROTEIN; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0031031951     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005772432465     Document Type: Article

References (34)

1. Chouvet C, Berger U, Coombes RC: 1,25-dihydroxyvitamin D3 inhibitory effect on the growth of two human breast cancer cell lines (MCF-7, BT-20). J Steroid Biochem 24: 373-376, 1986
2. Colston K, Chander SK, Maekay AG, Coombes RC: Effects of synthetic vitamin D analogs on breast cancer cell proliferation in vivo and in vitro. Biochem Pharm 44: 693-702, 1992
3. Vink-van Wijngaarden T, Pols H, Buurman CJ, van den Bemd G, Dorssers L, Birkenhager J, van Leeuwen J: Inhibition of breast cancer cell growth by combined treatment with vitamin D, analogues and tamoxifen. Cancer Research 54: 5711-5717, 1994
4. 3 in MCF-7 breast cancer cells. In: Norman AW, Bouillon R, Thomasett M (eds) Proceedings of the Ninth Workshop on Vitamin D. Walter DeGruyter & Co., Berlin, 1994
5. Welsh JE: Induction of apoptosis in breast cancer cells in response to vitamin D and antiestrogens. Biochem Cell Biol 72: 537-545, 1994
6. 3: coordinate regulator of active cell death and proliferation in MCF-7 breast cancer cells. In: Tenniswood M, Michna H (eds) Sehering Foundation Workshop, Vol. 14: Workshop on Apoptosis in Hormone Dependent Cancers. Springer Verlag, Berlin p. 181-200, 1995
7. Kyprianou N, English H, Davidson N, Isaacs J: Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation. Cancer Research 51: 162-166, 1991
8. Warri AM, Huovinen RL, Laine AM, Martikainen PM, Harkonen PL: Apoptosis in toremifene-induced growth inhibition of human breast cancer cells in vivo and in vitro. J Natl Cancer Inst 85: 1412-1418, 1993
9. Guenette RS, Corbeil H, Leger J, Wong K, Mezl V, Mooibroek M, Tenniswood M: Induction of gene expression during involution of the lactating mammary gland of the rat. J Mol Endo 12: 47-60, 1994
10. 3 analogues: a novel class of potent regulators of cell growth and immune responses. Bioehem Pharm 42: 1569-1575, 1991
11. Colston K, Maekay AG, James SY, Binderup L: EB1089: a new vitamin D analogue that inhibits the growth of breast cancer cells in vivo and in vitro. Biochem Pharm 44: 2273-2280, 1992
12. 3 derivatives and breast cancer. In: Tenniswood M, Michna H (eds) Schering Foundation Workshop, Vol. 14: Workshop on Apoptosis in Hormone Dependent Cancers. Springer Verlag, Berlin, p. 181-200, 1995
13. James SY, Maekay A, Binderup L, Colston K: Effects of a new synthetic vitamin D analog, EB1089, on the oestrogen responsive growth of human breast cancer cells. J Endo 141: 555-563, 1994
14. 3 resistant MCF-7 cell line. Endocrinology 137: 400-409, 1996
15. James SY, Mackay A, Colston K: Vitamin D derivatives in combination with 9-cis retinoic acid promote active cell death in breast cancer cells. J Mol Endo 14: 391-394, 1995
16. Bellomo G, Perotti M, Taddei F, et al.: Tumor necrosis factor a induces apoptosis in mammary adenocarcinoma cells by an increase in intranuclear tree calcium concentration and DNA fragmentation. Cancer Res 52: 1342-1346, 1992
17. Dowd DR, MacDonald PN, Komm BS, Haussler MR, Miesfield RL: Stable expression of the calbindin D28K complementary DNA interferes with the apoptotic pathway in lymphocytes. Mol Endocrinol 6: 1843-1848, 1992
18. Mezettie G, Monti MG, Casolo P, Piccinini G, Moruzzi MS: 1,25-dihydroxycholecalciferol dependent calcium uptake by mouse mammary gland in culture. Endocrinology 122: 389-394, 1988
19. Simboli-Campbell M, Miller M, Zhu XM, Franks DJ, Williamson DG: Modulation of a renal estrogen receptor by protein kinase C. Receptors and Channels 2: 33-40, 1994
20. Walker PR, Kwast-Welfeld J, Gourdeau H, Leblanc J, Neugebauer W, Sikorska M: Relationship between apoptosis and the cell cycle in lymphocytes: roles of protein kinase C, tyrosine phosphorylation and API. Experimental Cell Research 207: 142-151, 1993
21. Tenniswood M, Guenette RS, Lakins J, Mooibroek M, Wong P, Welsh JE: Active cell death in hormone dependent tissues. Cancer and Metastasis Reviews 11: 197-220, 1992
22. Tenniswood MP, Taillefer D, Lakins J, Guenette RS, Mooibroek M, Daehlin L, Welsh JE: Control of gene expression during apoptosis in hormone dependent tissues. In: Tomei LD, Cope FO (eds) Apoptosis: The Molecular Basis of Cell Death, Vol II. Cold Spring Harbor Laboratory Press, 283-311, 1994
23. Lanzerotti RH, Gullino PM: Activities and quantities of lysosomal enzymes during mammary tumor regression. Cancer Res 32: 2679-2685, 1972
24. Guenette RS, Mooibroek M, Wong K, Wong P, Tenniswood M: Cathepsin B, a cysteine protease implicated in metastatic progression, is also expressed during regression of the rat prostate and mammary glands. Eur J Biochem 226: 311-321, 1994
25. Reed JC: Bcl-2 and the regulation of programmed cell death. J Cell Biol 124: 1-6, 1994
26. Craig RW: The BCL-2 gene family. Seminars in Cancer Biology 6: 35-43, 1995
27. Wang TTY, Phang JM: Effects of estrogen on apoptotic pathways in human breast cancer cell line MCF-7. Cancer Research 55: 2487-2489, 1995
28. Sumantran VN, Ealovega MW, Nunez G, Clarke MF, Wicha MS: Overexpression of Bcl-x sensitizes MCF-7 cells to chemotherapy induced apoptosis. Cancer Research 55: 2507-2510, 1995
29. Eisman J, Sutherland RL, McMenemy ML, Fragonas JC, Musgrove EA, Pang G: Effects of 1,25-dihydroxy vitamin D3 on cell cycle kinetics of T47D human breast cancer cells. J Cell Physiol 138: 611-616, 1989
30. 3 analogues: a novel class of potent inhibitors of proliferation and inducers of differentiation of human breast cancer cells. Cancer Research 55: 2822-2830, 1995
31. 3 is linked to dephosphorylation of retinoblastoma gene product. Biochem Biophys Res Commun 196: 487-493, 1993
32. Yen A, Varvayanis S: Late dephosphorylation of the RB protein in G2 during the process of induced cell differentiation. Exper Cell Res 214: 250-257, 1994
33. 3 and TGFβ in IEC-6 cells. In: Norman AW, Bouillon R, Thomasett M (eds) Proceedings of the Ninth Workshop on Vitamin D. Walter DeGruyter & Co., Berlin, 1994
34. 3 in breast cancer cells occur at the estrogen response element level but through different molecular mechanisms. Cancer Res 54: 1458-1464, 1994